A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5

被引:60
作者
Bikah, G
Lynd, FM
Aruffo, AA
Ledbetter, JA
Bondada, S
机构
[1] Univ Kentucky, Dept Immunol & Microbiol, Lexington, KY 40536 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[3] Bristol Myers Squibb Pharmaceut Res Inst, Seattle, WA 98121 USA
关键词
CD5; T cell; B cell;
D O I
10.1093/intimm/10.8.1185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD5 is a glycoprotein expressed at a high level on the surface of mature T lymphocytes. Studies with CD5 mAb and CD5-deficient mice have shown that the CD5 molecules have a significant role in T cell growth response. However, the precise role of CD5 in immune cell interactions is still unclear. The present study provides evidence that CD5 plays a direct role in providing growth signals during the contact-dependent activation and proliferation of splenic a cells. An anti-CDS mAb inhibited T(h)1- and T(h)2-type cell-induced a cell proliferation. CD5-Ig, a chimeric fusion protein, induced proliferation of resting a cells. Flow cytometric analyses using CD5-Ig and mAb to CD72 demonstrated that CD5 bound to a ligand (CD5L), and this binding was not blocked by a variety of anti-CD72 mAb, Also, CD5-Ig did not bind to CD72(+)-transfected cells. Immunoprecipitation of surface labeled a cell molecules with CD5-Ig showed that CD5L was composed of 77-80 and 38-40 kDa polypeptide chains, distinct from CD72, CD5L was expressed on activated splenic a cells, but not T cells, whereas its expression was constitutive on peritoneal a cells and on a lymphoma cell lines.
引用
收藏
页码:1185 / 1196
页数:12
相关论文
共 49 条
[1]  
ALBEROLAILA J, 1992, J IMMUNOL, V148, P1287
[2]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[3]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[4]   MULTIPLE ACTIN GENES ENCODING THE SAME ALPHA-MUSCLE ISOFORM ARE EXPRESSED DURING ASCIDIAN DEVELOPMENT [J].
BEACH, RL ;
JEFFERY, WR .
DEVELOPMENTAL BIOLOGY, 1992, 151 (01) :55-66
[5]   Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes [J].
Biancone, L ;
Bowen, MA ;
Lim, A ;
Aruffo, A ;
Andres, G ;
Stamenkovic, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :811-819
[6]   CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells [J].
Bikah, G ;
Carey, J ;
Ciallella, JR ;
Tarakhovsky, A ;
Bondada, S .
SCIENCE, 1996, 274 (5294) :1906-1909
[7]  
BIKAH G, 1995, 9 INT C IMM
[8]   CD5 ACTS AS A TYROSINE KINASE SUBSTRATE WITHIN A RECEPTOR COMPLEX COMPRISING T-CELL RECEPTOR ZETA-CHAIN CD3 AND PROTEIN-TYROSINE KINASES P56LCK AND P59FYN [J].
BURGESS, KE ;
YAMAMOTO, M ;
PRASAD, KVS ;
RUDD, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9311-9315
[9]  
CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457
[10]  
CAMBIER JC, 1987, ANNU REV IMMUNOL, V5, P175, DOI 10.1146/annurev.immunol.5.1.175